Viewing Study NCT04999969

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:08 PM
Ignite Modification Date: 2026-01-27 @ 6:59 AM
Study NCT ID: NCT04999969
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-26
First Post: 2021-08-03
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced or Metastatic Solid Tumours View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AZD0171 View
None Durvalumab View
None Gemcitabine View
None Nab-paclitaxel View
None Leukaemia inhibitory factor View
None Pancreatic ductal adenocarcinoma View
None Immunotherapy View